Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

Overview of attention for article published in BMC Cancer, October 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 1,548 followers.

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer https://t.co/Ir6NlMQ7lm #cancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.